FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle

Bahman Aghdasi, Keqiang Ye, Adam Resnick, Alex Huang, Hyo Chol Ha, Xin Guo, Ted M Dawson, Valina Dawson, Solomon H Snyder

Research output: Contribution to journalArticle

Abstract

FKBP12, the 12-kDa FK506-binding protein, is a ubiquitous abundant protein that acts as a receptor for the immunosuppressant drug FK506, binds tightly to intracellular calcium release channels and to the transforming growth factor β (TGF-β) type 1 receptor. We now demonstrate that cells from FKBP12-deficient (FKBP12-/-) mice manifest cell cycle arrest in G1 phase and that these cells can be rescued by FKBP12 transfection. This arrest is mediated by marked augmentation of p21(WAF1/CIP1) levels, which cannot be further augmented by TGF-β1. The p21 up-regulation and cell cycle arrest derive from the overactivity of TGF-β receptor signaling, which is normally inhibited by FKBP12. Cell cycle arrest is prevented by transfection with a dominant-negative TGF-β receptor construct. TGF-β receptor signaling to gene expression can be mediated by SMAD, p38, and ERK/MAP kinase (extracellular signal-regulated kinase/mitogen-activated protein kinase) pathways. SMAD signaling is down-regulated in FKBP12-/- cells. Inhibition of ERK/MAP kinase fails to affect p21 up-regulation. By contrast, activated phosphorylated p38 is markedly augmented in FKBP12-/- cells and the p21 up-regulation is prevented by an inhibitor of p38. Thus, FKBP12 is a physiologic regulator of cell cycle acting by normally down-regulating TGF-β receptor signaling.

Original languageEnglish (US)
Pages (from-to)2425-2430
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume98
Issue number5
DOIs
StatePublished - Feb 27 2001

Fingerprint

Tacrolimus Binding Protein 1A
Tacrolimus Binding Proteins
Transforming Growth Factors
Growth Factor Receptors
Cell Cycle
Extracellular Signal-Regulated MAP Kinases
Cell Cycle Checkpoints
Up-Regulation
Transfection
Drug Receptors
G1 Phase
Tacrolimus
p38 Mitogen-Activated Protein Kinases
Calcium Channels
Immunosuppressive Agents
Mitogen-Activated Protein Kinases
Gene Expression

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle. / Aghdasi, Bahman; Ye, Keqiang; Resnick, Adam; Huang, Alex; Ha, Hyo Chol; Guo, Xin; Dawson, Ted M; Dawson, Valina; Snyder, Solomon H.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, No. 5, 27.02.2001, p. 2425-2430.

Research output: Contribution to journalArticle

@article{f270c9a30f9445c38db653bba6b10530,
title = "FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle",
abstract = "FKBP12, the 12-kDa FK506-binding protein, is a ubiquitous abundant protein that acts as a receptor for the immunosuppressant drug FK506, binds tightly to intracellular calcium release channels and to the transforming growth factor β (TGF-β) type 1 receptor. We now demonstrate that cells from FKBP12-deficient (FKBP12-/-) mice manifest cell cycle arrest in G1 phase and that these cells can be rescued by FKBP12 transfection. This arrest is mediated by marked augmentation of p21(WAF1/CIP1) levels, which cannot be further augmented by TGF-β1. The p21 up-regulation and cell cycle arrest derive from the overactivity of TGF-β receptor signaling, which is normally inhibited by FKBP12. Cell cycle arrest is prevented by transfection with a dominant-negative TGF-β receptor construct. TGF-β receptor signaling to gene expression can be mediated by SMAD, p38, and ERK/MAP kinase (extracellular signal-regulated kinase/mitogen-activated protein kinase) pathways. SMAD signaling is down-regulated in FKBP12-/- cells. Inhibition of ERK/MAP kinase fails to affect p21 up-regulation. By contrast, activated phosphorylated p38 is markedly augmented in FKBP12-/- cells and the p21 up-regulation is prevented by an inhibitor of p38. Thus, FKBP12 is a physiologic regulator of cell cycle acting by normally down-regulating TGF-β receptor signaling.",
author = "Bahman Aghdasi and Keqiang Ye and Adam Resnick and Alex Huang and Ha, {Hyo Chol} and Xin Guo and Dawson, {Ted M} and Valina Dawson and Snyder, {Solomon H}",
year = "2001",
month = "2",
day = "27",
doi = "10.1073/pnas.041614198",
language = "English (US)",
volume = "98",
pages = "2425--2430",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "5",

}

TY - JOUR

T1 - FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle

AU - Aghdasi, Bahman

AU - Ye, Keqiang

AU - Resnick, Adam

AU - Huang, Alex

AU - Ha, Hyo Chol

AU - Guo, Xin

AU - Dawson, Ted M

AU - Dawson, Valina

AU - Snyder, Solomon H

PY - 2001/2/27

Y1 - 2001/2/27

N2 - FKBP12, the 12-kDa FK506-binding protein, is a ubiquitous abundant protein that acts as a receptor for the immunosuppressant drug FK506, binds tightly to intracellular calcium release channels and to the transforming growth factor β (TGF-β) type 1 receptor. We now demonstrate that cells from FKBP12-deficient (FKBP12-/-) mice manifest cell cycle arrest in G1 phase and that these cells can be rescued by FKBP12 transfection. This arrest is mediated by marked augmentation of p21(WAF1/CIP1) levels, which cannot be further augmented by TGF-β1. The p21 up-regulation and cell cycle arrest derive from the overactivity of TGF-β receptor signaling, which is normally inhibited by FKBP12. Cell cycle arrest is prevented by transfection with a dominant-negative TGF-β receptor construct. TGF-β receptor signaling to gene expression can be mediated by SMAD, p38, and ERK/MAP kinase (extracellular signal-regulated kinase/mitogen-activated protein kinase) pathways. SMAD signaling is down-regulated in FKBP12-/- cells. Inhibition of ERK/MAP kinase fails to affect p21 up-regulation. By contrast, activated phosphorylated p38 is markedly augmented in FKBP12-/- cells and the p21 up-regulation is prevented by an inhibitor of p38. Thus, FKBP12 is a physiologic regulator of cell cycle acting by normally down-regulating TGF-β receptor signaling.

AB - FKBP12, the 12-kDa FK506-binding protein, is a ubiquitous abundant protein that acts as a receptor for the immunosuppressant drug FK506, binds tightly to intracellular calcium release channels and to the transforming growth factor β (TGF-β) type 1 receptor. We now demonstrate that cells from FKBP12-deficient (FKBP12-/-) mice manifest cell cycle arrest in G1 phase and that these cells can be rescued by FKBP12 transfection. This arrest is mediated by marked augmentation of p21(WAF1/CIP1) levels, which cannot be further augmented by TGF-β1. The p21 up-regulation and cell cycle arrest derive from the overactivity of TGF-β receptor signaling, which is normally inhibited by FKBP12. Cell cycle arrest is prevented by transfection with a dominant-negative TGF-β receptor construct. TGF-β receptor signaling to gene expression can be mediated by SMAD, p38, and ERK/MAP kinase (extracellular signal-regulated kinase/mitogen-activated protein kinase) pathways. SMAD signaling is down-regulated in FKBP12-/- cells. Inhibition of ERK/MAP kinase fails to affect p21 up-regulation. By contrast, activated phosphorylated p38 is markedly augmented in FKBP12-/- cells and the p21 up-regulation is prevented by an inhibitor of p38. Thus, FKBP12 is a physiologic regulator of cell cycle acting by normally down-regulating TGF-β receptor signaling.

UR - http://www.scopus.com/inward/record.url?scp=0035956972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035956972&partnerID=8YFLogxK

U2 - 10.1073/pnas.041614198

DO - 10.1073/pnas.041614198

M3 - Article

C2 - 11226255

AN - SCOPUS:0035956972

VL - 98

SP - 2425

EP - 2430

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 5

ER -